C12Y 305/03015
Protein-arginine deiminase
Official title: Protein-arginine deiminase (3.5.3.15)
C12Y305/03015 (Protein-arginine deiminase) appears on 9 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 25
- Assignees
- 15
- Inventors
- 55
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 2 | 3 |
| 2023 | 0 | 3 |
| 2024 | 0 | 2 |
| 2025 | 2 | 1 |
| 2026 | 2 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Antigen and antibodies prepared based on PADI4 serving as tumor marker, and application thereof3 Mar 2026US 12,566,177 B2Shandong Xinchuang Biological Technology Co., Ltd.
- Anti-PAD2 antibody24 Feb 2026US 12,559,570 B2Pharma Foods International Co., Ltd.
- Anti-PAD4 antibody21 Oct 2025US 12,448,464 B2Pharma Foods International Co., Ltd.
- Anti-PAD2 antibody for treating and evaluating autoimmune and inflammatory diseases29 Jul 2025US 12,372,524 B2The Johns Hopkins University
- Bacterial inhibitors22 Nov 2022US 11,504,414 B2
- Reprogramming method27 Aug 2026US 2026/0250639 A1The Babraham Institute
- Novel anti-pad2 antibody4 Jun 2026US 2026/0152572 A1Pharma Foods International Co., Ltd.
- Novel anti-pad4 antibody30 Apr 2026US 2026/0116998 A1Pharma Foods International Co., Ltd.
- Composition and method for inhibiting fibrosis24 Jul 2025US 2025/0236683 A1Pharma Foods International Co., Ltd.
- Novel anti-pad4 antibody19 Sep 2024US 2024/0309112 A1Mitsubishi Tanabe Pharma Corporation
Most cited
By later US patents
- Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof1US 11,208,386 B2University of Massachusetts · 2021
- Anti-PAD4 antibody1US 11,447,569 B2Pharma Foods International Co., Ltd. · 2022
- Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis1US 9,267,946 B2Inserm (Institut National De La Sante Et De La Rec · 2016